Design and Baseline Characteristics for the Aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II) - Concepedia

Concepedia

Publication | Closed Access

Design and Baseline Characteristics for the Aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)

250

Citations

35

References

1999

Year

B. I. Freedman, Jean-Paul Wuerth, Kenneth Cartwright, Raymond P. Bain, Stephen E. Dippe, Kenneth S. Hershon, A. D. Mooradian, Bruce S. Spinowitz

Controlled Clinical Trials

Diabetes ManagementRenal FunctionRenal DiseaseKidney FailureAminoguanidine Clinical TrialChronic Kidney DiseasePharmacologyDiabetesAction IiDiabetic Kidney DiseaseBaseline CharacteristicsMedicineNephrology

References

	Year	Citations

Page 1

Page 1